baber/WOPTO huggingface dataset:
Patent NZ-547167-A (NZ)
Title: Derivatives of N-[phenyl(pyrrolidine-2-yl)methyl]benzamide and N-[(azepan-2-yl)phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics
Inventor: DARGAZANLI GIHAD
IPC: A61P25/00
Filed: 2004-10-15
Abstract: Disclosed is a compound corresponding to the general formula (I) in which n represents the number 1 or 3, R1 represents either a hydrogen atom, a linear or branched (C1 -C7)alkyl group optionally substituted with one or more fluorine atoms, a (C3-C7)cycloalkyl group, a (C3 C7) cycloalkyl (C1 -C3) alkyl group, a phenyl(C1 -C3)alkyl group optionally substituted with one or two methoxy groups, a (C2-C4) alkenyl group, or a (C2 -C4) alkynyl group, X represents either a hydrogen atom or one or more substituents chosen from halogen atoms and trifluoromethyl and linear or branched (C1 -C6) alkyl and (C1 -C6) alkoxy groups, R2 represents either a hydrogen atom or one or more substituents chosen from halogen atoms and trifluoromethyl, linear or branched (C1 -C6) alkyl and (C1 -C6) alkoxy, (C3-C7) cycloalkyl, phenyl, cyano, acetyl, benzoyl, S (C1 -C6) alkyl, (C1 -C6) alkylsulfonyl, carboxyl and (C1 -C6) alkoxycarbonyl groups, or a group of general formula NR3R4, SO2NR3R4 or CONR3R4, in which R3 and R4 represent, independently of each other, a hydrogen atom or a linear or branched (C1 -C6)alkyl or (C3-C7) cycloalkyl group, or form, with the nitrogen atom that bears them, a pyrrolidine, piperidine or morpholine ring, in the form of base or of acid-addition salt. Also disclosed is the use if the above compound of formula (I) in the preparation of the medicament for the treating of behavioural disorders associated with dementia, psychosis, various forms of anxiety, panic attacks, phobia, compulsive obsessive disorders, various forms of depression, disorders caused by alcohol abuse or weaning from alcohol, sexual behaviour disorders, eating disorders and migraine, contracture, pain, Parkinson's disease and Parkinson like symptoms, epilepsy, mixed forms epileptic syndromes in addition to antiepileptic treatment, or in monotherapy, apnea, and for neuroprotection.
Patent NZ-547368-A (NZ)
Title: Liquid evacuation device and corresponding liquid guiding device
Inventor: BARBE PIERRE
IPC: E04D13/04
Filed: 2004-11-09
Abstract: A device for evacuating a liquid, comprising an evacuation tube (6) forming an evacuation inlet (12), a collector tub (8) provided with a flange (16) and a liquid guiding device (10). A plate (20) of the device covers the evacuation inlet (12). The plate (20) comprises a peripheral area (24) facing the flange (16). An evacuation opening (26) is arranged in the peripheral area. Two liquid guiding elements (40) are provided for each opening (26) in the annular space between the cover plate (20) and the flange (16). The guiding element (40) comprises a radial branch (44) and a circumferential branch. Application: rainwater evacuation devices.
Patent NZ-548386-A (NZ)
Title: Novel acylalkylisethionate esters and applications in consumer products
Inventor: ANANTANENI PRAKASA R
IPC: C11D1/28
Filed: 2004-08-11
Abstract: Disclosed is a process useful for forming an aqueous composition of matter comprising a mixture of alkyl-substituted hydroxyethane sulfonates comprising the steps of: a) providing at least one alkylene oxide having between 3 and 8 carbon atoms per molecule; b) providing an aqueous solution comprising bi-sulfite anions; c) contacting the aqueous solution with the alkylene oxide while maintaining the pH at a range between about 6.0 and about 10.0, wherein the mixture of alkyl-substituted hydroxyethane sulfonates comprises: i) a first anion having the structure of formula (I) wherein one of R1 and R2 is a straight chain or branched C1 to C6 alkyl group and the remaining R1 and R2 is hydrogen; and ii) a second anion having the structure of formula (II) wherein one of R3 and R4 is a straight chain or branched C1 to C6 alkyl group and the remaining R3 and R4 is hydrogen.
Patent NZ-549021-A (NZ)
Title: Headband with tension indicator and oximetry sensor
Inventor: HANNULA DON
IPC: A41D20/00
Filed: 2005-02-11
Abstract: A headband comprises a low stretch segment 202 sized to fit around a wearer's head, an elastic segment 204 smaller than the low stretch segment 202 where the elastic segment 204 has a free end and is attached to the low stretch segment 202 at the other end, and a sensor configured to be placed against the wearer's head and be held in position by pressure from the headband. The free end of the elastic segment 204 is configured to form a closed loop with the low stretch segment 202 around the wearer's head.
Patent NZ-561061-A (NZ)
Title: Bodyspray having adjustable spray orientation
Inventor: KAJUCH PETE
IPC: B05B15/68
Filed: 2006-02-28
Abstract: A bodyspray assembly is provided that includes a bi-directional coupling assembly (66) connected to a spray face (24). The spray face is operable to emit a directed spray having an omni-directionally adjustable angular orientation. Hence, a spray face in the form of a tile having an array of outlets can direct spray in a variety of directions, or be parallel to a mounting wall for decorative purposes.
Patent NZ-561252-A (NZ)
Title: Improved insulation for baking chambers in a multi-deck baking oven
Inventor: WILLETT PAUL EATON
Filed: 2007-09-07
Abstract: A multi-deck baking oven including a housing and at least two baking chambers located within the housing, adjacent baking chambers being separated by an insulating layer, at least one of the insulating layers including a hollow partition, wherein each insulating layer dampens the rate of heat flow between the adjacent baking chambers.
Patent NZ-565252-A (NZ)
Title: Crosslinking method
Inventor: SUCH CHRISTOPHER HENRY
IPC: C07C67/347
Filed: 2006-06-30
Abstract: Disclosed is a method of preparing a crosslinked polymer, which method comprises polymerising branched polyunsaturated monomers by a metathesis polymerisation reaction, wherein the branched polyunsaturated monomers contain terminal or near terminal acyclic ethylenically unsaturated groups that are capable of undergoing polymerisation by a metathesis reaction such that the metathesis polymerisation produces a crosslinked polymer, and wherein the branched polyunsaturated monomers are, or are derived from, a natural oil. Also disclosed is a coating or adhesive product comprising said monomers.
Patent NZ-573824-A (NZ)
Title: French fry production method with reduced crumb generation
Inventor: HAMMAN MICHAEL L
IPC: A23L27/60
Filed: 2007-07-02
Abstract: A process of parfrying and freezing potato products to eliminate the generation of crumbs upon the finish fry preparation of the potato product. The process comprises the steps: a. Blanching the potato products in hot water or steam; b. Parfrying the product of (a) once in hot zero grams Trans Fat (ZGTF) oil at a frying temperature to produce parfried potato products having a moisture content of greater than about 60 percent by weight; c. Applying a water-based spray to product of (b) at a water temperature less than 68 degrees Celsius, without overspray, to surface hydrate the potato product to achieve an overall product weight increase from 1 percent to 11 percent; d. Freezing the product of (c); and e. Finish fry preparation of the (d) in hot oil at a frying temperature.
Patent NZ-583564-A (NZ)
Title: Materials and Methods For Respiratory Disease Control in Canines
Inventor: GIBBS PAUL J
IPC: C12N5/078
Filed: 2006-04-21
Abstract: Provided is an isolated polynucleotide that comprises all or part of a genomic segment or gene of a canine influenza virus wherein said genomic segment or gene comprises a polynucleotide that encodes a polypeptide comprising a specified amino acid sequence or a functional and/or immunogenic fragment thereof, or said polynucleotide encodes a polypeptide having greater than 99% sequence identity with the amino acid sequence. The composition can be used in the manufacture of vaccines for dogs.
Patent NZ-588195-A (NZ)
Title: Topical formulations comprising polydimethylsiloxane derivatives and benzalkonium chloride for the prevention of sexually transmitted diseases
Inventor: LICHTBLAU CRAIG
IPC: A61K8/02
Filed: 2008-03-27
Abstract: Disclosed is an oil-in-water cream emulsion suitable for the prevention of sexually transmitted diseases, characterized by enhanced skin protective properties consisting of in combination: (1) dimethicone 20 (i.e. a polydimethylsiloxane derivative), in the range of 10.0 to 20.0 % wt/wt; (2) dimethicone 12500, in the range of 3.0-10.0 % wt/wt; (3) zinc oxide, in the range of 1.0 to 8.0 % wt/wt; (4) a mixture of cetearyl alcohol and ceteareth-20, in the range of 6.0 to 10.0 % wt/wt; (5) glycerin, in the range of 2.0 to 10.0 % wt/wt; (6) ceteareth-12, in the range of 0.5 to 3.0 % wt/wt; (7) disodium edetate, in the range of 0.01 to 0.1 % wt/wt; (8) benzalkonium chloride, in the range of 0.01 to 0.25 % wt/wt; (9) anhydrous lanolin, in the range of 0.5 to 3.0 % wt/wt; (10) cetostearyl alcohol, in the range of 1.0 to 5.0 % wt/wt; (11) cetyl alcohol, in the range of 1.0 to 5.0 % wt/wt; and (12) a sufficient quantity of deionized water to form the cream; and wherein said cream is formulated such that on contact with the skin a skin protective barrier layer is formed. (61) Addition to 600568
Patent NZ-588391-A (NZ)
Title: Blow molded polyester container with an over-molded thermoplastic layer
Inventor: SHI YU
IPC: B29B11/08
Filed: 2009-04-06
Abstract: Disclosed is a blow molded container (20) of a construction intended to make it appeal to a customer on a store shelf. The container has a container body (22) and a container dispensing exit. The container body comprises a thermoplastic body layer and a plurality of thermoplastic over-mold layers (15), simultaneously formed from a preform. The plurality of thermoplastic over-mold layers are over-molded directly to the outer surface of the thermoplastic body layer over a portion of the thermoplastic body layer. The thermoplastic body layer is one of substantially transparent or a first color and each of the thermoplastic over-mold layers are each of different colors, one from the other. Further disclosed is a preform for making such a container.
Patent NZ-588401-A (NZ)
Title: An overmoulded container with a layer of elastomer only on the grip area and a method of making it
Inventor: SHI YU
IPC: B29C45/14
Filed: 2009-04-08
Abstract: A blow moulded container 22 is blow moulded with improved gripping areas. The gripping areas of the container contain a layer 20 a, 20 b of an elastomer which has a greater coefficient of friction than the coefficient of friction of the container surface. The elastomer is only on the gripping areas for that container with the surface of the remainder of the container being that of the container as formed. The container is formed from a preform 10 that has an elastomer layer 20 a, 20 b of a size and shape to produce the elastomer on the gripping area of the container, providing a blow mould with a negative of the container and gripping area on the inner surface of the mould, orienting the preform in the mould such that the elastomer layer on the preform is adjacent to the negative of the gripping area on the inner surface of the mould, and injecting a gas into the preform to blow mould the container with the gripping areas overloaded with a layer of the elastomer.
Patent NZ-590253-A (NZ)
Title: Production of potassium magnesium citrate and its applications
Inventor: PAIKIN MICHAEL
IPC: A23L33/15
Filed: 2009-06-02
Abstract: Disclosed is a magnesium rich composition comprising: (i) at least one source of magnesium; (ii) at least one source of potassium; and (iii) at least one source of citrate; wherein the composition has a bulk density of 0.35-0.75 g/cm3 and comprises from about 8% to about 15% (wt/wt) magnesium and from about 7.5% to about 16% (wt/wt) potassium and 75% to 80% citrate on dry weight basis. Also disclosed is a food product, in particular a milk-based beverage comprising the magnesium rich composition. Further disclosed is the method for producing a dried magnesium-rich composition.
Patent NZ-590256-A (NZ)
Title: INHALER CANISTER WITH PRIMELESS VALVE AND VOLUME LESS THAN 10mL
Inventor: COOK ROBERT O
IPC: A61M11/00
Filed: 2009-07-10
Abstract: 590256 A pressurized metered dose inhaler (100) is disclosed. The inhaler comprises a pressurized canister (140) comprising a plurality of discharge volumes of a medicament and a primeless valve (110). The inhaler is suitable for repetitive discharges of the medicament. The pressurized canister (110) is glass, plastic, metal or combinations thereof and has a total volume of less than about 10 millilitres. The inhaler reduces wastage of medicaments that are only available in restricted or controlled quantities.
Patent NZ-593255-A (NZ)
Title: A hydroelectric turbine comprising a passive brake and method of operation
Inventor: DUNNE PAUL
IPC: F03B11/06
Filed: 2009-12-14
Abstract: 593255 Disclosed is a hydroelectric turbine with a braking system so that the braking engages when bearing wear reaches an unsafe level. The turbine includes a stator and a rotor; at least one set of bearings supporting the rotor within the stator; and a brake which is operable to apply a braking force to the rotor upon a predetermined level of wear of the at least one set of bearings. The brake includes one or more sections of brake pad having a braking surface positioned radially inboard of a bearing surface of the at least one set of bearings with respect to the direction of wear of the bearing. Each section of the brake pad is formed integrally with the at least one set of bearings that includes journals mounted to the rotor and the bearing blocks mounted to the stator.
Patent NZ-597954-A (NZ)
Title: Mesh infrastructure utilizing priority repeaters and multiple transceivers
IPC: G01D4/02
Filed: 2012-02-01
Abstract: Disclosed is a wireless network (600) comprised of a control node (602) and a plurality of communication nodes (604a-604e, 606a-606f) in wireless communication with the control node (602). Each of the communication nodes (604a-604e, 606a-606f) has a wireless communication path to the control node (602) that is either a direct path or an indirect path through one or more other communication nodes (604a-604e, 606a-606f) that serve as repeaters. Some of the communication nodes (604a-604e) are designated as having a priority over other communication nodes (606a-606f) with respect to their service as repeaters. For communication nodes (604c-604e, 606a-606f) that are more than one hop from the control node (602), the control node (602) establishes communication paths first with the communication nodes (604a-604e) having priority over others (606a-606f) and subsequently with the remaining nodes (606a-606f).
Patent NZ-599269-A (NZ)
Title: Pharmaceutical compositions of rhein or diacerein
Inventor: DABRE RAHUL
IPC: A61K9/14
Filed: 2008-09-16
Abstract: 599269 Disclosed is a pharmaceutical composition comprising particles of rhein (4,5-dihydroxy-9,10-dioxoanthracene-2-carboxylic acid, Formula I) or diacerein (diacetylrhein, 4,5-diacetyloxy-9,10-dioxo-anthracene-2-carboxylic acid, Formula II) or salts or esters thereof optionally one or more pharmaceutically acceptable excipients, wherein the particles have an average particle size from about 0.1 microns to about 30 microns wherein the rhein or diacerein or salts or esters thereof is not co-micronized with surfactant. Also disclosed is the method for making the pharmaceutical composition.
Patent NZ-601942-A (NZ)
Title: Method for producing wind power plant rotor blades and a wind power plant rotor blade
Inventor: KANNENBERG JOHANNES
IPC: B29C44/12
Filed: 2011-02-18
Abstract: 601942 Disclosed is a process for the production of a wind power installation rotor blade to allow a more uniform impregnation of the composite fibres with resin. The steps include providing at least one mould and placing a layered fibre composite having at least one core or solid plate in the at least one mould, the core has a top side with first channel portions and an underside with second channel portions and connecting portions between the first and second channel portions. The first and second channel portions alternate along the length of the core. Resin is fed using a vacuum injection process through the first and/or second channel portions, until the layered fibre composite is adequately saturated.
Patent NZ-602958-A (NZ)
Title: High level expression of recombinant toxin proteins
Inventor: RETALLACK DIANE M
IPC: C12R1/39
Filed: 2011-03-28
Abstract: Discloses a method for producing a recombinant CRM197 toxin protein in a Pseudomonad (Pseudomonas) host cell, the method comprising transforming the pseudomonad host cell with an expression vector comprising an nucleotide sequence encoding a CRM197 toxin protein and culturing the transformed Pseudomonad host cell in a culture media suitable for expression of CRM197 toxin, wherein the toxin is produced at a yield of soluble and/or active protein of 0.2 grams/L to 12 grams/L.
Patent NZ-603171-A (NZ)
Title: Gate for barrier system and methods for the assembly and use thereof
Inventor: WILKINSON DOUGLAS E
IPC: E01F13/04
Filed: 2011-05-03
Abstract: 603171 A gate (16) for providing an opening in a barrier system is disclosed. The gate includes a gate barrier segment (18) and a connector having first and second connector segments (34, 36). The first connector segment (36) is coupled to the gate barrier segment. The first and second connector segments (34, 36) are releasably coupled, and may be hingedly connected (78) on at least one of a first and second side thereof. The second connector segment is configured to be coupled to a stationary barrier segment (2, 4).
Patent NZ-608751-A (NZ)
Title: Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol
Inventor: DIBAS MOHAMMED I
IPC: C07D233/64
Filed: 2011-09-16
Abstract: Provided are ester prodrugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol, of general Formula I, wherein the variables are as defined in the specification. Examples of the prodrugs include acetic acid 3-[(S)-1-(1H-imidazol-4-yl)-ethyl]-2-methyl-benzyl ester and 2-amino-3-phenyl-propionic acid 3-[(S)-1-(1H-imidazol-4-yl)-ethyl]-2-methyl-benzyl ester. [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol is a selective modulator of alpha 2 adrenergic receptors.
Patent NZ-625554-A (NZ)
Title: Vehicle
Inventor: YOSHIHISA TSUZUKI
IPC: F02M37/50
Filed: 2014-05-27
Abstract: A tractor with a front loader (2200) and an attaching frame (1100) for attaching to the side of a cabin (1010). The attaching frame (1100) is capable of being attached and/or detached from the cabin (1010). The attaching frame (1100) comprises a right side step (3000), pre-fuel filter (6100), main fuel filter (6200), and a fuel filter cover holding frame. The fuel filter cover holding frame allows attachment of a fuel filter cover (6300) to cover the fuel filter(s). The fuel filter cover can have a oil pressure hose attachment portion (6310) to which the front loader oil pressure hoses can be attached. The main fuel filter (6200) is placed in front of the pre-fuel filter (6100), with respect to the forward movement direction of the tractor. The pre-fuel filter (6100) is attached to the right side step in a position forward of the side step (3000). The main fuel filter (6200) is attached to the fuel cover holding frame. A seat (2000) may be mounted inside the cabin (1010), and the right side step aids a worker getting into the operating seat (2000). The attaching frame (1100) allows removal of multiple components attached therewith as a single unit.
Patent NZ-630230-A (NZ)
Title: Methods of treating pancreatic cancer
Inventor: DESAI NEIL P
IPC: A61P35/04
Filed: 2014-01-10
Abstract: Disclosed is a method of treating metastatic or locally advanced pancreatic cancer in a human individual comprising administering to the individual (a) an effective amount of a composition comprising nanoparticles comprising paclitaxel and an albumin; and (b) an effective amount of gemcitabine, wherein the individual is selected for treatment based on (i) having metastasis in the liver, (ii) having 3 or more metastatic sites, (iii) having pancreatic cancer in the primary location in the head of the pancreas, and/or (iv) having serum CA19-9 level that is greater than or equal to 59 x ULN (Upper Limit of Normal).
Patent NZ-704540-A (NZ)
Title: Improvements to amphibious vehicles, their methods of manufacture, and use
Inventor: ROBERT BUTLER GOWER
IPC: B60F3/00
Filed: 2014-09-12
Abstract: An amphibious vehicle including a hull and a wheel assembly. The wheel assembly may comprise at least one wheel and a drive motor. The wheel is rotatably mounted and the drive motor is coupled to the at least one wheel and configured to rotate a wheel. The wheel assembly (200) can be capable of retracting to within the hull, and a cover (250) can lie over top of the wheel (232) in it’s retracted position. The cover can be attached to the actuator by a cover linkage (not shown). The arrangement of the cover linkage could cause the cover to automatically open and/or close as the wheel is retracted or extended.
Patent NZ-710753-A (NZ)
Title: Jack assembly
Inventor: VAN DEN BOS JURGEN
IPC: F16M11/28
Filed: 2014-02-19
Abstract: A jockey wheel including a telescopic column for attachment to a towed vehicle, to raise and lower a draw bar of the vehicle, wherein the column includes a drive mechanism with a rotary input that rotates to cause the telescopic column to extend or retract; and a gear box with a rotary connector adapted to connect to and be driven by a power tool, wherein the gear box drives the input so as to provide for geared operation of the drive mechanism, and wherein the gear box further includes an input gear coupled to the rotary connector.
Patent NZ-716267-A (NZ)
Title: A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
Inventor: OKSCHE ALEXANDER
IPC: A61P25/04
Filed: 2014-07-23
Abstract: The present invention is concerned with an oral pharmaceutical dosage form comprising oxycodone or a pharmaceutically acceptable salt thereof and naloxone or a pharmaceutically acceptable salt thereof for use in the treatment of pain in patients suffering from i) pain and at least one further disease ii), wherein said at least one further disease ii) results in intestinal dysbiosis, or for use in the treatment of pain in patients suffering from i) pain and at least one further disease iii), wherein said at least one further disease iii) increases the risk for intestinal bacterial translocation and thus for peritonitis, SIRS and/or sepsis.
Patent NZ-719321-A (NZ)
Title: Storage stable lyophilized tripeptide formulations
Inventor: ABELS CHRISTOPH
IPC: A61K9/19
Filed: 2014-10-27
Abstract: The invention relates to Lysyl-Prolyl-Threonine (KPT) lyophilized formulations, in particular to L-Lysyl-D-Prolyl-L-Threonine lyophilized formulations, that are stable in storage, and to a process for preparing the lyophilized formulations. The lyophilized formulation comprises KPT or a pharmaceutically acceptable salt thereof, a bulking agent trehalose and a buffering agent citric acid. Moreover, the invention relates to pharmaceutical and cosmetic compositions comprising the lyophilized formulations, that are used in the therapeutic and/or prophylactic treatment, diagnosis and/or therapy of pain-related diseases, pruritus-related diseases, inflammatory diseases, and/or other diseases in a mammal.
Patent NZ-725814-A (NZ)
Title: Biaryl kinase inhibitors
Inventor: MACOR JOHN E
IPC: A61K31/495
Filed: 2015-04-01
Abstract: The present disclosure is generally directed to compounds of formula (I) which can inhibit AAK1 (adaptor associated kinase 1), compositions comprising such compounds, and methods for inhibiting AAK1.